GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Total Assets
中文

Virax Biolabs Group (Virax Biolabs Group) Total Assets : $7.03 Mil (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group Total Assets?

Virax Biolabs Group's Total Assets for the quarter that ended in Sep. 2023 was $7.03 Mil.

During the past 12 months, Virax Biolabs Group's average Total Assets Growth Rate was 163.00% per year.

Total Assets is connected with ROA %. Virax Biolabs Group's annualized ROA % for the quarter that ended in Sep. 2023 was -69.13%. Total Assets is also linked to Revenue through Asset Turnover. Virax Biolabs Group's Asset Turnover for the quarter that ended in Sep. 2023 was 0.01.

Virax Biolabs Group Total Assets Historical Data

The historical data trend for Virax Biolabs Group's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group Total Assets Chart

Virax Biolabs Group Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Total Assets
0.02 0.04 0.05 9.81

Virax Biolabs Group Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Total Assets Get a 7-Day Free Trial 0.04 0.05 5.30 9.81 7.03

Virax Biolabs Group Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Virax Biolabs Group's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets=Total Equity (A: Mar. 2023 )+Total Liabilities (A: Mar. 2023 )
=8.904+0.908
=9.81

Virax Biolabs Group's Total Assets for the quarter that ended in Sep. 2023 is calculated as

Total Assets=Total Equity (Q: Sep. 2023 )+Total Liabilities (Q: Sep. 2023 )
=6.106+0.919
=7.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virax Biolabs Group  (NAS:VRAX) Total Assets Explanation

Total Assets is connected with ROA %.

Virax Biolabs Group's annualized ROA % for the quarter that ended in Sep. 2023 is

ROA %=Net Income (Q: Sep. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=-5.82/( (9.812+7.025)/ 2 )
=-5.82/8.4185
=-69.13 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Virax Biolabs Group's Asset Turnover for the quarter that ended in Sep. 2023 is

Asset Turnover
=Revenue (Q: Sep. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=0.077/( (9.812+7.025)/ 2 )
=0.077/8.4185
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Virax Biolabs Group Total Assets Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Virax Biolabs Group (Virax Biolabs Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Total Assets
Comparable Companies
SILO IKT TENX XBIO KPRX HOTH ABVC APTX TSOI ZIVO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
20 North Audley Street, London, GBR, W1K 6LX
Website
https://www.viraxbiolabs.com
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.